United States· US:82667-021_494dc96c-0519-0b10-e063-6294a90ae904
BYQLOVI
A clobetasol product containing clobetasol propionate, registered in United States by Harrow Eye, LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CLOBETASOL PROPIONATE
- Manufacturer
- Harrow Eye, LLC
- Country
- United States (US)
- ATC code
- S01BA17
- ATC class
- Clobetasol
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1182667-021-00
- ndc1182667-021-05
- ndc1182667021001 BOTTLE, PLASTIC in 1 CARTON (82667-021-00) / 3.5 mL in 1 BOTTLE, PLASTIC
- ndc1182667021051 BOTTLE, PLASTIC in 1 CARTON (82667-021-05) / 3.5 mL in 1 BOTTLE, PLASTIC
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
218 interactions on record for clobetasol.
Graded by severity as the source publishes them — 218 info. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Clobetasol · interactions on record
218 records
Same medicine, other countries
Clobetasol in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomClarelux 500micrograms/g foamPierre Fabre Ltd
- PolandClareluxPierre Fabre Medicament
- CzechiaCLARELUXPierre Fabre Dermatologie, Boulogne
- CanadaCLOBEX SHAMPOOGALDERMA CANADA INC
- NetherlandsClarelux 500 microgram/g schuim voor cutaan gebruik in spuitbusPierre Fabre Medicament
- SwitzerlandClarelux
- Japanクロベタゾールプロピオン酸エステル佐藤製薬
- FranceCABESOL 500 microgrammes/g, shampooingLABORATOIRES MEDGEN
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Clarelux, Clobex
- Belgium · Cabesol, Clarelux
- Bulgaria · Дермоват, Инфилеа
- Cyprus · Dermovate, Medodermone
- Czechia · Clarelux, Clobetasol Belupo
- Germany · Clarelux, Clobegalen
- Denmark · Clobetasol Propionate Ifc, Clobetasolpropionat
- Estonia · Dermovate, Dermovate Ointment
- Spain · Clarelux, Clobex
- Finland · Clobex, Dermovat
- France · Cabesol, Clarelux
- United Kingdom (Northern Ireland) · Clarelux, Clobaderm
- Greece · Butavate, Clarelux
- Croatia · Cutibel
- Hungary · Clobex, Closanasol
- Ireland · Dermovate, Dermovate Scalp Application
- Iceland · Clobex, Dermovat
- Italy · Clobecare, Clobesol
- Lithuania · Closanasol, Dermovate
- Luxembourg · Cabesol, Clarelux
- Malta · Clobex, Dermovate
- Netherlands · Clarelux, Clobetasol Substipharm
- Norway · Clobex, Dermovat
- Poland · Clarelux, Clobederm
- Portugal · Clarelux, Clobetasol Basi
- Romania · Clobetasol Mk, Clobetazol Atb
- Sweden · Clobetasol Teva, Clobex
- Slovenia · Klobetazol Belupo
- Slovakia · Clarelux, Clobetasol Belupo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1acaed83-cc27-424a-b869-d601738e4bce GET /v1/drugs/1acaed83-cc27-424a-b869-d601738e4bce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": ".5",
"substance": "CLOBETASOL PROPIONATE",
"productndc": "82667-021",
"dosage_form": "FOR SUSPENSION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA218158",
"marketing_category": "NDA"
}See everything about clobetasol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.